Watch "2024 Updates on Clinical Trials in Neuroendocrine Tumors" >>>
Home
About
Learn
Advocate
Connect
Resources
More
Alpha PRRT with Pb-212 (all NET)
Lu-177 DOTATATE + Cabozantanib (all NET)
Lu-177 DOTATATE vs Everolimus in Lung NETs
Â
Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas
DAREONâ„¢- 5: DLL-3 BiTE for Neuroendocrine Cancers
Survivin Long Peptide Vaccine (SurVaxM) in Metastatic NETs
CABINET Randomized, Double-Blinded Phase III Study of Cabozantinib Versus Placebo in Patients with Advanced NETs After Progression on Prior Therapy
Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs)